Edition:
United States

Fate Therapeutics Inc (FATE.O)

FATE.O on Consolidated Issue listed on NASDAQ Global Market

15.88USD
14 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$15.88
Open
$15.78
Day's High
$16.47
Day's Low
$15.22
Volume
557,411
Avg. Vol
700,335
52-wk High
$17.98
52-wk Low
$4.13

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.97
Market Cap(Mil.): $876.81
Shares Outstanding(Mil.): 64.52
Dividend: --
Yield (%): --

Financials

  FATE.O Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.23 -- --
ROI: -48.47 0.60 13.80
ROE: -57.42 -2.18 15.29

Earnings vs. Estimates